# Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis

> **NCT00525902** · PHASE2 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 31 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT00525902
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2012-04-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00525902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00525902, "Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00525902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*